Clinical Trials on SARS-CoV-2 Viral Kinetics and Host Immune Responses in Argentina
Total 20 results
-
Hospital Italiano de Buenos AiresCompletedCOVID-19 | SARS-CoV-2 | SARS VirusArgentina
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
Hospital de Clinicas José de San MartínSILVATEAMTerminatedCOVID-19 | Coronavirus Infection | SARS-CoV 2Argentina
-
Ministerio de Salud de Ciudad Autónoma de Buenos...Completed
-
Hospital Italiano de Buenos AiresHospital de Niños R. Gutierrez de Buenos Aires; Salud Comunitaria Ministerio...Completed
-
Hospital Italiano de Buenos AiresSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious...UnknownCOVID-19 | Healthcare Workers | SARS-CoV 2Argentina
-
Fundación HuéspedMinisterio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...RecruitingCovid19 | SARS-CoV-2 Infection | Households ContactsArgentina
-
Hospital de Infecciosas Francisco Javier MunizCompletedCovid19 | SARS-CoV Infection | SARS-Associated CoronavirusArgentina
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedSARS-CoV 2 | COVID | COVID19 | DyspneaUnited States, Argentina, Denmark, United Kingdom
-
CureVacCompletedCovid19 | SARS-CoV-2Belgium, Spain, Germany, Argentina, Colombia, Dominican Republic, Mexico, Netherlands, Panama, Peru
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID)CompletedCOVID-19 | SARS-CoV-2United States, Malawi, Zimbabwe, Botswana, South Africa, Zambia, Argentina, Brazil, Mexico, Peru, Tanzania
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
University of ChileColumbia UniversityRecruitingDepression | Covid-19 | Anxiety | Mental Health Disorder | SARS-CoV-2 | Stress DisorderUnited States, Italy, Argentina, Armenia, Australia, Bolivia, Chile, Costa Rica, Czechia, Germany, Guatemala, Lebanon, Mexico, Netherlands, Nigeria, Puerto Rico, Saudi Arabia, Spain, Tunisia, Turkey, Venezuela
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...RecruitingInfluenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsRecruitingCovid19 | COVID | SARS-CoV2 InfectionUnited States, Spain, Argentina, Denmark, Greece, India, Mexico, Uganda
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusMexico, Peru, Thailand, South Africa, Russian Federation, Argentina, Brazil